Mutations in Apc and p53 synergize to promote mammary neoplasia

Cancer Research

Volumn 65, Issue 2, 2005, Pages 410-416

  Méniel, Valérie ^a   Hay, Trevor ^a   Douglas Jones, Anthony ^a   Sansom, Owen J ^a   Clarke, Alan R ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PROTEIN P21; PROTEIN P53;

ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER GROWTH; FEEDBACK SYSTEM; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RECOMBINATION; MAMMARY GLAND; METAPLASIA; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; WILD TYPE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BETA CATENIN; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOSKELETAL PROTEINS; FEMALE; FRAMESHIFT MUTATION; GENE SILENCING; GENES, APC; GENES, P53; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, EXPERIMENTAL; METAPLASIA; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PREGNANCY; TRANS-ACTIVATORS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 12544250382     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Kashiwaba M, Tamura G, Ishida M. Aberrations of the APC gene in primary breast carcinoma. J Cancer Res Clin Oncol 1994;120:727-31.
2. Thompson A, Morris R, Wallace M, Wyllie A, Steel C, Carter D. Allele loss from 5q21 (APC/MCC) and 18q21 (DCC) and DCC mRNA expression in breast cancer. Br J Cancer 1993;68:64-8.
3. Ho K, Kalle W, Lo THS, Lam W, Tang C. Reduced expression of APC and DCC gene protein in breast cancer. Histopathology 1999;35:249-56.
4. Schlosshauer P, Brown S, Eisenger K, et al. APC truncation and increased β-catenin levels in a human breast cancer cell line. Carcinogenesis 2000;21: 1453-6.
5. Woodage T, King S, Wacholder S. et al. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998;20:62-5.
6. Furuuchi K, Tada M, Yamada H, et al. Somatic mutations of the APC gene in primary breast cancers. American J Pathol 2000;156:1997-2005.
7. Jin Z, Tamura G, Tsuchiya T, et al. Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers. Br J Cancer 2001;85:69-73.
8. Moser AR, Mattes EM, Dove WF, Lindstrom MJ, Haag JD, Gould MN. ApcMin, a mutation in the murine Apc gene, predisposes to mammary carcinomas and focal alveolar hyperplasias. Proc Natl Acad Sci U S A 1993;90:8977-81.
9. Gallagher RC, Hay T, Meniel V, et al. Inactivation of Apc perturbs mammary development, but only directly results in acanthoma in the context of Tcf-1 deficiency. Oncogene 2002;21:6446-57.
10. Lin SY, Xia W, Wang JC, et al. β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000;97:4262-6.
11. Michaelson JS, Leder P. β-Catenin is a downstream effector of Wnt-mediated tumorigenesis in the mammary gland. Oncogene 2001;20:5093-9.
12. Imbert A, Eelkema R, Jordan S, Feiner H, Cowin P. ΔN89β- catenin induces precocious development, differentiation, and neoplasia in mammary gland. J Cell Biol 2001;153:555-68.
13. Miyoshi K, Shillingford JM, Le Provost F, et al. Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc Natl Acad Sci U S A 2002;99:219-24.
14. Wiseman BS, Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002;296:1046-9.
15. Coles C, Condie A, Chetty U, Steel CM, Evans HJ, Prosser J. p53 mutations in breast cancer. Cancer Res 1992;52:5291-8.
16. Gasco M, Yulug IG, Crook T. TP53 mutations in familial breast cancer: functional aspects. Hum Mutat 2003;21:301-6.
17. Damalas A, Ben-Ze'ev A, Simcha I, et al. Excess β-catenin promotes accumulation of transcriptionally active p53. EMBO J 1999;18:3054-63.
18. Sadot E, Geiger B, Oren M, Ben-Ze'ev A. Down-regulation of β-catenin by activated p53. Mol Cell Biol 2001;21:6768-81.
19. Shibata H, Toyama K, Shioya H, et al. Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene. Science 1997;278:120-3.
20. Selbert S, Bentley DJ, Melton DW, et al. Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res 1998;7:387-96.
21. Malcomson RD, Clarke AR, Peter A, Coutts SB, Howie SE, Harrison DJ. Apoptosis induced by γ-irradiation, but not CD4 ligation, of peripheral T lymphocytes in vivo is p53-dependent. J Pathol 1997;181:166-71.
22. Brisken C, Park S, Vass T, Lydon JP, O'Malley BW, Weinberg RA. A paracrine role for the epithelial progesterone receptor in mammary gland development. Proc Natl Acad Sci U S A 1998;95:5076-81.
23. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988;18:619-25.
24. Lane TF, Leder P. Wnt-10b directs hypermorphic development and transformation in mammary glands of male and female mice. Oncogene 1997;15:2133-44.
25. Sansom OJ, Reed KR, Hayes AJ, et al. Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration. Genes Dev 2004;18:1385-90.
26. Meniel V, Clarke AR. Wnt-cadherin connections in normal and neoplastic mammary epithelium. J Mammary Gland Biol Neoplasia 2003;8:435-47.
27. Jonkers J, Meuwissen R, van der Gulden H, Peterse H, van der Valk M, Berns A. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer. Nat Genet 2001;29:418-25.
28. Lin SC, Lee KF, Nikitin AY, et al. Somatic mutation of p53 leads to estrogen receptor α-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Res 2004;64:3525-32.
29. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 1999;21:70-1.
30. Kuperwasser C, Pinkas J, Hurlbut GD, Naber SP, Jerry DJ. Cytoplasmic sequestration and functional repression of p53 in the mammary epithelium is reversed by hormonal treatment. Cancer Res 2000;60:2723-9.
31. Kelsey JL, Gammon MD. The epidemiology of breast cancer. CA Cancer J Clin 1991;41:146-65.
32. Medina D. Breast cancer: the protective effect of pregnancy. Clin Cancer Res 2004;10:380-4S.
33. Medina D, Kittrell FS. p53 function is required for hormone-mediated protection of mouse mammary tumorigenesis. Cancer Res 2003;63:6140-3.
34. Sivaraman L, Conneely OM, Medina D, O'Malley BW. p53 is a potential mediator of pregnancy and hormone-induced resistance to mammary carcinogenesis. Proc Natl Acad Sci U S A 2001;98:12379-84.
35. Johansson EM, Kannius-Janson M, Bjursell G, Nilsson J. The p53 tumor suppressor gene is regulated in vivo by nuclear factor 1-C2 in the mouse mammary gland during pregnancy. Oncogene 2003;22:6061-70.